These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 7214664

  • 1. Clinical trials of misonidazole in the United States.
    Wasserman TH, Stetz J, Phillips TL.
    Cancer Clin Trials; 1981; 4(1):7-16. PubMed ID: 7214664
    [Abstract] [Full Text] [Related]

  • 2. Radiation Therapy Oncology Group clinical trials with misonidazole.
    Wasserman TH, Stetz J, Phillips TL.
    Cancer; 1981 May 15; 47(10):2382-90. PubMed ID: 7023642
    [Abstract] [Full Text] [Related]

  • 3. [Clinical trials of hypoxic cell sensitizer misonidazole].
    Onoyama Y.
    Gan No Rinsho; 1983 May 15; 29(6):718-25. PubMed ID: 6348345
    [Abstract] [Full Text] [Related]

  • 4. Phase I trial of intravenous L-phenylalanine mustard plus the sensitizer misonidazole.
    Coleman CN, Friedman MK, Jacobs C, Halsey J, Ignoffo R, Leibel S, Hirst VK, Gribble M, Carter SK, Phillips TL.
    Cancer Res; 1983 Oct 15; 43(10):5022-5. PubMed ID: 6883348
    [Abstract] [Full Text] [Related]

  • 5. [Clinical testing of the radiosensitizer RO-07-0582 (misonidazole). Dose tolerance, toxicity and pharmacokinetic studies, preliminary report (author's transl)].
    Bataini JP, Bernier J, de Narbonne J, Brugère J, Jaulerry C, Brunin F.
    Bull Cancer; 1978 Oct 15; 65(4):482-5. PubMed ID: 371710
    [No Abstract] [Full Text] [Related]

  • 6. Preliminary results of RTOG phase I/II study of misonidazole and radiation for bladder cancer.
    Mohiuddin M, Kramer S, Phillips T, Soberon M, Forgione H.
    Am J Clin Oncol; 1982 Oct 15; 5(5):551-4. PubMed ID: 7180834
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. New side effect of the hypoxic cell sensitizer, misonidazole.
    Partington J, Koziol D, Chapman D, Rabin H, Urtasun RC.
    Cancer Treat Rep; 1979 Jan 15; 63(1):123-5. PubMed ID: 217536
    [Abstract] [Full Text] [Related]

  • 13. The value of adjuvant misonidazole in the definitive irradiation of advanced head and neck squamous cancer: an RTOG pilot study (#78-02).
    Fazekas JT, Goodman RL, McLean CJ.
    Int J Radiat Oncol Biol Phys; 1981 Dec 15; 7(12):1703-8. PubMed ID: 7333912
    [No Abstract] [Full Text] [Related]

  • 14. Palliation of liver metastases with combined hepatic irradiation and misonidazole. Results of a Radiation Therapy Oncology Group Phase I-II study.
    Leibel SA, Order SE, Rominger CJ, Asbell SO.
    Cancer Clin Trials; 1981 Dec 15; 4(3):285-93. PubMed ID: 6169464
    [No Abstract] [Full Text] [Related]

  • 15. The Cambridge glioma trial of misonidazole and radiation therapy with associated pharmacokinetic studies.
    Bleehen NM.
    Cancer Clin Trials; 1980 Dec 15; 3(3):267-73. PubMed ID: 7002338
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A national trial on the treatment of invasive bladder cancer.
    Arnold EP, Bailey C, Burry AF, Bydder PV, Firth LA, Gowland S, Gray AJ, Mcllroy R.
    N Z Med J; 1981 Apr 22; 93(682):273-5. PubMed ID: 7019784
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.